pharma · Atopic Dermatitis · Seborrheic Keratosis · ACRS
Aclaris Therapeutics
Aclaris Therapeutics clinical programs — 25 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 170 N Radnor Chester Rd, Radnor Township, Pennsylvania, US
- Founded
- 2012
- Employees
- 10
- Programs
- 33
- Drugs
- 12
- Patents
- 18
Aclaris Therapeutics projects
25 ClinicalTrials.gov programs sponsored by Aclaris Therapeutics.
Aclaris Therapeutics has 25 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
A-101
Aclaris Therapeutics
Seborrheic Keratosis
2 trials -
A-101 25%
Aclaris Therapeutics
Seborrheic Keratosis (SK)
1 trial -
A-101 Solution 40
Aclaris Therapeutics
Common Warts
1 trial -
A-101 Topical Solution
Aclaris Therapeutics
Common Wart
2 trials -
A-101 Topical Solution 40%
Aclaris Therapeutics
Dermatosis Papulosa Nigra
1 trial -
A-101 Vehicle
Aclaris Therapeutics
Seborrheic Keratosis
1 trial -
ATI 502 0.46% Topical Solution
Aclaris Therapeutics
Alopecia Areata
1 trial -
ATI-045
Aclaris Therapeutics
Atopic Dermatitis
1 trial -
ATI-045, Placebo to ATI-045
Aclaris Therapeutics
Atopic dermatitis
1 trial -
ATI-1777
Aclaris Therapeutics
Atopic Dermatitis
1 trial -
ATI-1777 2.0% w/w
Aclaris Therapeutics
Atopic Dermatitis
1 trial -
ATI-2138
Aclaris Therapeutics
Atopic Dermatitis
1 trial -
ATI-450
Aclaris Therapeutics
Cryopyrin-Associated Periodic Syndrome
1 trial -
ATI-450
Aclaris Therapeutics
Hidradenitis Suppurativa
1 trial -
ATI-450
Aclaris Therapeutics
Psoriatic Arthritis
1 trial -
ATI-450
Aclaris Therapeutics
Rheumatoid Arthritis
1 trial -
ATI-450 50 mg oral tablet BID
Aclaris Therapeutics
Rheumatoid Arthritis
1 trial -
ATI-50002
Aclaris Therapeutics
Androgenetic Alopecia
1 trial -
ATI-50002
Aclaris Therapeutics
Alopecia Areata
1 trial -
ATI-50002 high dose
Aclaris Therapeutics
Alopecia Areata
1 trial -
ATI-50002 topical solution
Aclaris Therapeutics
Vitiligo
1 trial -
ATI-501 400mg BID (Low dose)
Aclaris Therapeutics
Alopecia
1 trial -
ATI-502
Aclaris Therapeutics
Atopic Dermatitis
1 trial -
Vehicle
Aclaris Therapeutics
Alopecia Universalis (AU)
1 trial -
Zumsemetinib
Aclaris Therapeutics
Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer
1 trial
Frequently asked questions
How many clinical projects does Aclaris Therapeutics have?
25 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.